QSAM Biosciences is engaged in the development of radiopharmaceutical medicines for cancer treatment. The company is planning to go public on 7 April by listing on the NASDAQ. We’re studying the issuer’s financial performance and trying to find out whether the stock might find its audience among investors.
All posts
Rail Vision develops cutting-edge safety systems for the railway industry, implementing artificial intelligence in its products. The company’s IPO will take place on 25 March 2022. We are analysing the business and financial reports to determine whether the stock will find its audience among investors.
Dynasty Financial Partners Inc. developed a SaaS platform for wealth management. The is planning to go public by listing on the NASDAQ. We are analysing the issuer's business model and financial reports to determine how interesting the stock might be for investment.
Basis Global Technologies developed a SaaS platform that helps enterprises to optimize expenses for online advertising. The IPO of Basis Global Technologies will be held at the NASDAQ. We’re taking a closer look at the company’s business modal and financial performance, and trying to determine how interesting the stock might be for investment.